Burkhardt et al: Evaluating preoperative coagulation panels in dogs undergoing liver lobectomy for primary liver tumors: A multi-institutional retrospective study
Veterinary Surgery 7, 2024

🔍 Key Findings

  • 20.6% of dogs had a preoperative prolongation in PT or aPTT, but only 5.6% had both prolonged.
  • Hemangiosarcoma was the only tumor type significantly associated with both PT and aPTT prolongation (37.5% of hemangiosarcoma cases, p < .001).
  • Dogs with both PT and aPTT prolongations were 6.5× more likely to have emergency surgery (p < .001) and 2.5× more likely to have hemoabdomen (p = .0022).
  • 60% of dogs with both PT and aPTT prolongation required blood transfusion (p < .001).
  • Only 1.9% of all dogs had both PT and aPTT prolonged by >25%, suggesting limited clinical utility of routine PT/aPTT testing.
  • Platelet count <50,000/μL was rare (1.5%) and not associated with PT/aPTT changes or transfusions.
  • Routine PT/aPTT testing offers low diagnostic yield in elective liver lobectomy cases.
  • Authors recommend case-by-case PT/aPTT screening, especially when hemangiosarcoma or bleeding tendencies are suspected.

Simini Surgery Review Podcast

How critical is this paper for crushing the Boards?

🚨 Must-know. I’d bet on seeing this.

📚 Useful background, not must-know.

💤 Skip it. Doubt it’ll ever show up.

Thanks for the feedback!
We'll keep fine-tuning the articles vault.
Oops — didn’t go through.
Mind trying that again?